Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Oct;12(10):1238-42.
doi: 10.1128/CDLI.12.10.1238-1242.2005.

Fluorescent multivalent opsonophagocytic assay for measurement of functional antibodies to Streptococcus pneumoniae

Affiliations

Fluorescent multivalent opsonophagocytic assay for measurement of functional antibodies to Streptococcus pneumoniae

Kathryn T Bieging et al. Clin Diagn Lab Immunol. 2005 Oct.

Abstract

We developed fluorescent mono- and multivalent opsonophagocytic assays (fOPA and fmOPA, respectively) specific for seven Streptococcus pneumoniae serotypes (4, 6B, 9V, 14, 18C, 19F, and 23F). Bacterial survival was quantitated with alamar blue, a fluorescent metabolic indicator. Both fOPA and fmOPA allow for determination of viability endpoints for up to seven serotypes with high levels of agreement to the reference method. The fmOPA eliminates colony counting, reduces serum volume, and produces results in 1 day.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Signal-to-noise ratios for five alamar blue reaction mixtures with various bacterial inocula. Signal was defined as mean fluorescence in the presence of bacteria. Noise was defined as the mean fluorescence of the reagent blanks in the absence of bacteria for each corresponding buffer condition. The total incubation period was 4 h. Reaction mixtures contained various concentrations of THYE and a constant concentration (10%) of alamar blue. The mixtures were tested with several concentrations of S. pneumoniae serotype 6B, reference strain DS2212-94 (63 to 4,000 CFU in a 20-μl well volume). At 4,000 CFU, the signal ranged from 82,358 FU with 25% THYE to 93,714 FU for 100% THYE. The blanks ranged from 5,966 FU with 25% THYE to 15,660 FU with 100% THYE. Thus, the optimized formulation (greatest signal-to-noise ratio) was obtained with 25% THYE.
FIG. 2.
FIG. 2.
Identity graphs comparing fmOPA titers to the reference multilaboratory OPA titers (19) for seven serotypes as shown in panels A to G. The solid line is the linear regression; the broken line is the line of identity. The size of the data point represents the number of serum samples that are at that coordinate (n = 24).
FIG. 2.
FIG. 2.
Identity graphs comparing fmOPA titers to the reference multilaboratory OPA titers (19) for seven serotypes as shown in panels A to G. The solid line is the linear regression; the broken line is the line of identity. The size of the data point represents the number of serum samples that are at that coordinate (n = 24).

References

    1. Black, S. B., H. R. Shinefield, S. Ling, J. Hansen, B. Fireman, D. Spring, J. Noyes, E. Lewis, P. Ray, J. Lee, and J. Hackell. 2002. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr. Infect. Dis. J. 21:810-815. - PubMed
    1. Bogaert, D., M. Sluijter, R. de Groot, and P. W. M. Hermans. 2004. Multiplex opsonophagocytosis assay (MOPA): a useful tool for the monitoring of the 7-valent pneumococcal conjugate vaccine. Vaccine 22:4014-4020. - PubMed
    1. Capeding, M. Z. R., T. Puumalainen, C. P. Gepanayao, H. Käyhty, M. G. Lucero, and H. Nohynek. 10. August 2003, posting date. Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein-conjugated pneumococcal vaccine in Filipino infants. BMC Infect. Dis. 3:17. [Online.] http://www.biomedcentral.com/1471-2334/3/17. - PMC - PubMed
    1. Cutts, F. T., S. M. A. Zaman, G. Enwere, S. Jaffar, O. S. Levine, J. B. Okoko, C. Oluwalana, A. Vaughan, S. K. Obaro, A. Leach, K. P. McAdam, E. Biney, M. Saaka, U. Onwuchekwa, F. Yallop, N. F. Pierce, B. M. Greenwood, and R. A. Adegbola. 2005. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomized, double-blind, placebo-controlled trial. Lancet 365:1139-1146. - PubMed
    1. Flannery, B., S. Schrang, N. M. Bennett, R. Lynfield, L. H. Harrison, A. Reingold, P. R. Cieslak, J. Hadler, M. M. Farley, R. R. Facklam, E. R. Zell, and C. G. Whitney. 2004. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA 291:2197-2203. - PubMed

Publication types